Data Characteristics
Psychiatric drug safety data originates from clinical trial reports, real-world studies, adverse event reporting systems (e.g., international drug regulatory databases), literature reviews, and patient follow-up records. This data updates frequently, especially adverse event reports, which may see daily additions. Document structures vary, including unstructured free text descriptions, semi-structured case report forms, and structured coded data (e.g., ICD-10, MedDRA codes). Beyond routine patient demographics, medication history, and diagnostic information, specific fields of interest include psychiatric symptom scale scores (e.g., HAM-D, PANSS), cognitive function assessment results, adverse event timelines, severity, outcomes, and causality assessments related to medication. Dosage units may involve milligrams and milliliters, requiring attention to administration routes and frequencies.
Constraints Imposed by These Characteristics on Model Integration and Configuration
The multi-source and complex nature of psychiatric drug safety data imposes specific requirements on model integration and configuration. Highly free-form unstructured text demands stronger text understanding capabilities to extract key information. Semi-structured and structured data require models to effectively integrate information from different formats. High update frequency means models need to support incremental learning or periodic retraining to maintain timeliness. Specific fields, such as psychiatric symptom scale scores, have clinically significant numerical changes; models must preserve their semantic integrity during extraction. Adverse event time-series data requires models with time-series analysis capabilities to identify event trends. The presence of specialized medical codes like MedDRA means models need to possess or integrate external tools for professional medical terminology mapping to standardize descriptions across different reports.
Configuration Guidelines
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
Chunk size (Chunk Size) | 500-800 characters | Psychiatric adverse event reports often contain detailed descriptions. This length helps preserve contextual integrity and prevents truncation of key information. |
Chunk Overlap Length (Overlap Length) | 100-150 characters | Ensures sufficient overlap between chunks to capture cross-chunk relational information, such as symptom-drug causality. |
Recall count (Recall Count) | 8-12 items | Psychiatric drug safety queries typically require more comprehensive information. Increasing the recall count helps cover potential relevant adverse events. |
Similarity threshold (Similarity Threshold) | 0.75-0.85 | Given the linguistic variability in adverse event descriptions, this threshold balances relevance while avoiding over-strictness that could lead to omissions. |
Rerank result count (Reranked Return Count) | 5 items | Reranked models can provide more precise results. Limiting the count helps engineers quickly focus on core information. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Processing large clinical trial reports or aggregated adverse event files requires a longer file parsing time to avoid timeouts. |
Common Mistakes
- Model calls result in "request entity too large" or "context length exceeded" errors. This occurs when
Chunk size(Chunk Size) ormaxContextparameters are not adjusted for the lengthy nature of psychiatric reports. - The model fails to accurately identify trends in psychiatric symptom scale scores. This happens when specific numerical fields are not properly formatted or semantically annotated during data preprocessing, causing the model to treat them as plain text.
- Query results lack the most recently published adverse event reports. This is due to the model not having a configured periodic data source synchronization mechanism or an incomplete incremental update strategy, leading to outdated knowledge base information.
How to Verify Configuration
- Randomly select multiple psychiatric adverse event reports. Query them using the configured model. Check if the returned results include core drug, symptom, dosage, and other key information from the reports, and assess their completeness.
- For data containing psychiatric symptom scale scores, conduct question-answering tests. Confirm if the model can correctly extract and interpret score changes. Threshold settings should align with clinical professional judgment.
- Simulate newly added adverse event reports. Import them into the knowledge base and immediately query. Verify if the model can recall and process new data within a short time. Threshold settings should reflect the actual business requirements for timeliness.
The values provided are common starting points. They should be measured against specific samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.